embecta.com (EMBC) Quarterly EPS earnings growth
Embecta Corp. (EMBC) relies on a narrow segment of diabetes care products, which necessitates the development of digital services. A global reach spanning a hundred countries and new pumps mitigate technological risks. The quarterly relative change in EPS confirms this trend, where the -54.10 level captures the current state. However, pressure from Asian peers and competition for patient loyalty constrain the business's margins.
%20Year-over-year%20earnings%20per%20share%20growth%20for%20the%20last%2012%20months&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_EMBC_-_Embecta-Corp._-_Year-over-year-earnings-per-share-growth-for-the-last-12-months "EMBC: embecta.com Year-over-year net earnings per share growth for the last 12 months 04/28/2023 - 11/10/2026 | 👁️GURU.Markets👁️")
Analytical breakdowns for Embecta Corp.
- share price and expert price forecast:
- market capitalization details:
- balance sheet net asset value indicators:
- debt and solvency information:
- earnings and valuation multiples information:
EMBC - Net Profit|Expected Profit Embecta Corp.|EMBC - Price to Earnings Ratio|Projected Price to Earnings Embecta Inc.|EMBC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Embecta Inc.|EMBC - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Embecta|EMBC - Net earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months embecta.com|EMBC - Earnings growth in current year|Earnings growth forecast for next year Embecta Corp.
Summary company analysis:Embecta - EMBC
Robotic production of insulin pen needles at Embecta Corp. (EMBC) minimizes costs, directly impacting the bottom line. Automation efficiency is reflected in the quarterly EPS growth calculation through a percentage comparison of current earnings against the same period last year. This metric measures the pace of fundamental business development between official reports. The positive trend confirms the issuer's financial stability. By analyzing the quarterly earnings per share dynamics, an investor can timely identify the risk of overpaying when purchasing the asset.
Competitors of Embecta Corp. (EMBC)
BSX: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Edwards (EW)|RMD (ResMed Corp) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months PODD (Insulet Inc.)|Year-over-year net earnings per share growth for the last 12 months ZBH (Zimmer Biomet)|COO (coopercos.com) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Align Technology ALGN|GMED - Year-over-year net earnings per share growth for the last 12 months|TransMedics Organ Care System - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Alphatec Corp|AORT: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ENOV|IART (Integra LifeSciences Holdings Corporation) - Quarterly EPS earnings growth|Establishment Labs Corp (ESTA) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth BBNX|Year-over-year net earnings per share growth for the last 12 months IRADIMED Inc. IRMD|Quarterly EPS earnings growth TNDM (Tandem Diabetes Care)|Quarterly EPS earnings growth axogeninc.com AXGN|SIBN - Year-over-year earnings per share growth for the last twelve months|OFIX: Year-over-year earnings per share growth for the last twelve months|BVS (Bioventus Corp) - Year-over-year net earnings per share growth for the last 12 months|OrthoPediatrics - Year-over-year earnings per one share growth for the last 12 months|TMCI (Treace Medical Concepts) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months blade.com SRTA|Year-over-year earnings per share growth for the last twelve months Carlsmed (CARL)|RxSight Inc (RXST) - Net earnings per share growth for the trailing year|ClearPoint Neuro - Year-over-year net earnings per share growth for the last 12 months|Quarterly EPS earnings growth Stereotaxis Corporation STXS|Neuronetics, Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months sightsciences.com SGHT|Orchestra BioMed (OBIO) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months ANIK (Anika Therapeutics, Inc.)|Year-over-year earnings per share growth for the last twelve months InspireMD Corp|Year-over-year net earnings per share growth for the last 12 months Jin Medical International Ltd (ZJYL)|Quarterly EPS earnings growth VANI|XTNT - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months NeuroOne Medical Technologies Corporation NMTC|MODD: Year-over-year earnings per share growth for the last 12 months|MYO: Year-over-year net earnings per share growth for the last 12 months|Envoy Medical Inc - Year-over-year earnings per share growth rate for the last twelve months|VVOS: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months envveno.com (NVNO)|Year-over-year earnings per share growth for the last twelve months Sintx Technologies Inc|Year-over-year net earnings per share growth for the last 12 months Tenon Medical Inc. (TNON)|Quarterly EPS earnings growth LFWD|Year-over-year earnings per share growth for the last twelve months AMIX (autonomix.com)|Quarterly EPS earnings growth IVF (INVO Fertility Inc)|bonebiologics.com (BBLG) - Earnings per share growth in annualized terms for the last twelve months|Axonics - Quarterly EPS earnings growth|BIOLASE Inc. (BIOL) - Year-over-year net earnings per share growth for the last 12 months|DYNT (dynatronics.com) - Year-over-year net earnings per share growth for the last 12 months|FNA: Year-over-year earnings per share growth rate for the last twelve months|INVO (INVO Bioscience Inc.) - Quarterly EPS earnings growth
